43 results on '"Schnetzler, Gabriel"'
Search Results
2. Abstract CT176: Pharmacokinetic/pharmacodynamic (PK/PD) relationships of the novel Treg depleter RG6292 in Phase Ia and Ib studies in patients with solid tumors
3. Abstract CT110: Safety and anti-tumor activity of a novel Treg depleter RG6292, as a single agent and in combination with atezolizumab in patients with solid tumors
4. Data from Activity and Resistance of a Brain-Permeable Paradox Breaker BRAF Inhibitor in Melanoma Brain Metastasis
5. Supplementary Table from Preclinical Characterization of a Next-Generation Brain Permeable, Paradox Breaker BRAF Inhibitor
6. Supplementary Data from Preclinical Characterization of a Next-Generation Brain Permeable, Paradox Breaker BRAF Inhibitor
7. Supplementary Data from Activity and Resistance of a Brain-Permeable Paradox Breaker BRAF Inhibitor in Melanoma Brain Metastasis
8. Activity and resistance of a brain-permeable paradox breaker BRAF inhibitor in melanoma brain metastasis
9. The Ability of the General Male Public to Assess Their Suitability to Take 50‐mg Sildenafil: An Assessment of the Comprehension of Patient Information Materials via Internet Survey
10. A Feasibility Study Comparing Pharmacist and Physician Recommendations for Sildenafil Treatment
11. Preclinical Characterization of a Next-Generation Brain Permeable, Paradox Breaker BRAF Inhibitor
12. Interrelationship of Sildenafil Treatment Effects on the Physiological and Psychosocial Aspects of Erectile Dysfunction of Mixed or Organic Etiology
13. The EPIFARM Study: An Observational Study in 574 Community Pharmacies in Spain Characterizing Patient Profiles of Men Asking for Erectile Dysfunction Medication
14. Understanding the Effects of Sildenafil Treatment on Erection Maintenance and Erection Hardness
15. The Ability of Men to Assess their Suitability to Take a Phosphodiesterase Type 5 Inhibitor: An Assessment of the Comprehension of Patient Information Materials
16. ORIGINAL RESEARCH—ED PHARMACOTHERAPY: Characteristics, Behaviors, and Attitudes of Men Bypassing the Healthcare System When Obtaining Phosphodiesterase Type 5 Inhibitors
17. Emotional Changes in Men Treated With Sildenafil Citrate for Erectile Dysfunction: A Double‐Blind, Placebo‐Controlled Clinical Trial
18. Scoring Correspondence in Outcomes Related to Erectile Dysfunction Treatment on a 4-Point Scale (SCORE-4)
19. Overview of Guidelines and Recommendations for the Planning, Conduct and Reporting of Company-Sponsored Observational, Noninterventional Studies in Europe
20. Vismodegib (ERIVEDGE) pregnancy prevention programme: assessment of risk awareness.
21. Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults
22. Testosterone measurement - mandatory in ALL men with ED - a response
23. Abstract 4553: The CD25 antibody RG6292 selectively depletes Tregs while preserving IL-2 signaling and CTL activity for tumor control
24. Neues Weiterbildungsprogramm in Pharmazeutischer Medizin
25. Vismodegib (ERIVEDGE) pregnancy prevention programme: assessment of risk awareness
26. Model‐based approach for methoxy polyethylene glycol‐epoetin beta drug development in paediatric patients with anaemia of chronic kidney disease
27. The EPIFARM Study: An Observational Study in 574 Community Pharmacies in Spain Characterizing Patient Profiles of Men Asking for Erectile Dysfunction Medication
28. Characteristics, Behaviors, and Attitudes of Men Bypassing the Healthcare System When Obtaining Phosphodiesterase Type 5 Inhibitors
29. Efficacy, tolerability and satisfaction with sildenafil citrate 100-mg titration compared with continued 50-mg dose treatment in men with erectile dysfunction
30. Evolution to a Competency-Based Training Curriculum for Pharmaceutical Medicine Physicians in Switzerland
31. Dose Escalation of HLA-A2-WT1 CD3 T-Cell Bispecific Antibody in a Phase I Study in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)
32. Malaria chemoprophylaxis regimens: A descriptive drug utilization study
33. Validation of a treatment satisfaction questionnaire in non-Hodgkin lymphoma: assessing the change from intravenous to subcutaneous administration of rituximab
34. Estudio EPIFARM
35. Malaria chemoprophylaxis regimens: A descriptive drug utilization study
36. Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers
37. Pharmaceutical quality of eight generics of ceftriaxone preparation for injection in Eastern Asia
38. Testosterone measurement - mandatory in ALL men with ED - a response
39. Pharmaceutical quality of eight generics of ceftriaxone preparation for injection in Eastern Asia
40. Induction of the IL-10 gene via the Fas receptor in monocytes - an anti-inflammatory mechanism in the absence of apoptosis
41. Induction of the IL-10 gene via the Fas receptor in monocytes an anti-inflammatory mechanism in the absence of apoptosis
42. Preclinical Characterization of a Next-Generation Brain Permeable, Paradox Breaker BRAF Inhibitor.
43. Invasive aspergillosis: is treatment with "inexpensive" amphotericin B cost saving if "expensive" voriconazole is only used on demand?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.